XClose

UCL-TB

Home
Menu

About Us

 

tb-about-us

What is UCL-TB?

UCL-TB is a broad and cross-disciplinary Tuberculosis research network that spans University College London and our partners throughout the world. Our mission is to research the prevention, treatment and cure of TB in communities with, and at risk of, the disease. Drawing on our researchers' diverse skill-set and expertise, UCL-TB's programmes include basic science, translational research, clinical trials, and implementation and evaluation of large scale projects in local communities, and across the world.

Who we are

UCL-TB comprises over 30 Principal Investigators with a focus on TB research ranging from innovative bench work, to improving the health of the public. Our UCL-TB Management Group is guided by the steering group who meet once every six months. The membership of UCL-TB is extensive and includes people beyond UCL. If you would like to join this network please get in touch (tb@ucl.ac.uk)

What we do

UCL-TB's cutting-edge outputs impact nationally and internationally. We have a particular focus on London through our role within UCLPartners, whose geographical footprint contains almost 25% of the annual TB cases in England. Our association with the new biomedical discovery Francis Crick Institute offers unrivalled reach and basic science facilities. The UCL MRC Clinical Trials Unit is internationally renowned for its work in Infection and TB; and continues to lead in this field. We are also building new relationships and collaborations that enable us to work to promote interdisciplinary research, from running events in conjunction with our partners at the London School for Hygiene and Tropical Medicine, to helping develop strategy with Public Health England, the European Respiratory Society and the World Health Organisation.

Our grant success and publications are recognised nationally and internationally. Our students and post-graduates highly recommend working with us as they become the next global generation of researchers, scientists and clinical academics.

We are keen to explore new ways of working to further innovative research.